GSK3B and Parkinson disease: Finally, to precisely evaluate the role of GSK-3β in PD-related cell death, we inhibited GSK-3β activity using two selective GSK-3β inhibitors, LiCl and kenpaullone, and gene silencing with a siRNA targeting GSK-3β.